Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

PURPOSE: Subsets of pituitary tumors exhibit an aggressive clinical courses and recur despite surgery, radiation, and chemotherapy. Because modulation of the immune response through inhibition of T-cell checkpoints has led to durable clinical responses in multiple malignancies, we explored whether p...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Mei, Yu, Bi, Wenya Linda, Greenwald, Noah F., Du, Ziming, Agar, Nathalie Y. R., Kaiser, Ursula B., Woodmansee, Whitney W., Reardon, David A., Freeman, Gordon J., Fecci, Peter E., Laws, Edward R., Santagata, Sandro, Dunn, Gavin P., Dunn, Ian F.
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363530/
https://ncbi.nlm.nih.gov/pubmed/27655724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12088
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料